THERAPEUTICS
Metformin plus a lifestyle intervention was more effective than either alone for antipsychotic-induced weight gain
| The first 150 words of the full text of this article appear below. |
J P Zhao
Dr J P Zhao, Second Xiangya Hospital, Changsha, China; wurenrong2005@yahoo.com.cn
STUDY DESIGN
randomised placebo controlled trial.
concealed.*
blinded (data collectors, {patients, data analysts, safety committee, and manuscript writers}
).*
STUDY QUESTION
schizophrenia outpatient clinic in China.
128 patients 18–45 years of age (mean age 26 y, 50% men) who were diagnosed with a first psychotic episode of schizophrenia, gained >10% of predrug weight in year 1 of antipsychotic treatment (clozapine, olanzapine, sulpiride, or risperidone), were taking only 1 antipsychotic with
25% change in dose in the past 3 months, first attended the clinic or were discharged from an inpatient unit <1 year before enrolment, had relatively stable improvement (Positive and Negative Symptom Scale total score
60), and had an adult caregiver who could monitor adherence. Exclusion criteria were liver or renal dysfunction, cardiovascular disease, diabetes mellitus, history of substance abuse, pregnancy or lactation, inability to perform the lifestyle intervention (LSI), and
University of Extremadura Medical School and University Hospital Network, Badajoz, Spain
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
